-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Amrize, Raises Price Target to $59

Benzinga·01/29/2026 14:31:52
Listen to the news
Wells Fargo analyst Timna Tanners maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $58 to $59.